EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
WG1
GML is trying to find a date for a face-to-face meeting of WG1. It is currently very difficult since the group is split between two dates (23rd June and 15th September). He will see if there is more availability on 27th October or 3rd November (after Rahul confirms).
Endorsement letter – national associations
Did you see Gonzalo’s email? Can we send the letter?
WG3+4
GML would like to know when the face-to-face meeting for the merged WG3+4 should be organised. We could have it in September (only possibilities 15th (but only if WG1 is not meeting) or 29th) to give directions for the meetings of national associations with competent authorities and to prepare the communication package. Or we could organise it in December/January to plan the meeting in Barcelona with competent authorities and to discuss possible problems that members faced during their meeting with national competent authorities.
We have a large number of incomplete responses. EAHP Presidents and delegates have been encouraged to send reminder to their members to complete the survey.
Annual report – ideas
I will start working on this agenda item after the GA.
Endorsement policy
The minutes of the last Board meeting suggest that SK and JP work on the endorsement policy and have something ready by 1st September? When would you like to start working on it? Please note I am on holidays for 3 weeks in August.
EJHP piece on Brexit/shortages/FMD
JP during the Board meeting you indicated that you could start to draft an article.
FIP reference paper on Women and Responsible use of medicines (deadline 27 May) we won’t submit a response as discussed during the Board meeting weekend.
Richard emailed the letter to the Commission (see HERE). In addition to ECCO, ESOP and EAH, the letter is further supported by the European Oncology Nursing Society (EONS) and the European Society for Paediatric Oncology (SIOPE).
NVZA is also interested, but they only voiced their interest yesterday to Richard.
PGEU and the Commission confirmed. I am still waiting on a reply from UEMS and the MEP. In case both (or one) don’t have time which other organisation should I contact for a meeting?
PGEU cancelled. Do you want to still come to Brussels or shall we consider to reschedule?
MOIC
How shall we proceed with MOIC after they sent the MoU (see HERE)?
CPME HTA
Joan, you wanted to discuss the position of CPME on the HTA proposal (see HERE). I will also give you a brief oral update on the meeting with the Commissioner (the report will be ready hopefully by this Wednesday).
FIP Call for Nominations for Hospital Pharmacy Section Executive Committee
FYI – besides Inese also Ioan Antofie has expressed interest.
CPME and PGEU cooperation
Inese shared paper of CPME/PGEU on doctor-pharmacist collaboration in addressing non-adherence (see HERE) with the SC. She suggested our involvement since it concerns pharmacist collaboration. Should we discuss this with Ilaria on 23rd May?
Request McKesson (wholesale + retail company; member of GIRP) – FIP session
McKesson EU will be participating in this year’s FIP congress. They are looking at focussing one WebEx session on transitional care – that is, what processes can ensure the best pharmaceutical outcomes for patients when they transition from hospital back to community pharmacy, or vice versa.
Is this something EAHP has looked at from a policy perspective or, perhaps do we have amongst our members an expert/s who might be willing to share some expertise?
ESNO event – biosimilar guide launch
Shall I attend?
